Gene Ther. 2000 May;7(10):859-66.

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.

Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D, Petty R, MacLean A, Harland J, McKie E, Mabbs R, Brown M.

Source

Beatson Oncology Centre, Western Infirmary, Glasgow, UK.

Abstract

The herpes simplex virus (HSV) ICP34.5 null mutant 1716 replicates selectively in actively dividing cells and has been proposed as a potential treatment for cancer, particularly brain tumours. We present a clinical study to evaluate the safety of 1716 in patients with relapsed malignant glioma. Following intratumoural inoculation of doses up to 10(5) p.f.u., there was no induction of encephalitis, no adverse clinical symptoms, and no reactivation of latent HSV. Of nine patients treated, four are currently alive and well 14-24 months after 1716 administration. This study demonstrates the feasibility of using replication-competent HSV in human therapy.

Comment in

Gene Ther. 2000 May;7(10):815-6.

PMID:: 10845724; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Save items

Related citations in PubMed

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. [Gene Ther. 2000]
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.
Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, Palmer CA, Feigenbaum F, Tornatore C, Tufaro F, et al. Gene Ther. 2000 May; 7(10):867-74.
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. [Gene Ther. 2002]
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.
Papanastassiou V, Rampling R, Fraser M, Petty R, Hadley D, Nicoll J, Harland J, Mabbs R, Brown M. Gene Ther. 2002 Mar; 9(6):398-406.
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. [Gene Ther. 2004]
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.
Harrow S, Papanastassiou V, Harland J, Mabbs R, Petty R, Fraser M, Hadley D, Patterson J, Brown SM, Rampling R. Gene Ther. 2004 Nov; 11(22):1648-58.
Review Oncolytic virus therapy using genetically engineered herpes simplex viruses. [Hum Cell. 2002]
Review Oncolytic virus therapy using genetically engineered herpes simplex viruses.
Todo T. Hum Cell. 2002 Sep; 15(3):151-9.
Review Oncolytic virus therapy using genetically engineered herpes simplex viruses. [Front Biosci. 2008]
Review Oncolytic virus therapy using genetically engineered herpes simplex viruses.
Todo T. Front Biosci. 2008 Jan 1; 13:2060-4. Epub 2008 Jan 1.

See reviews... See all...

Cited by 60 PubMed Central articles

ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN. [Drugs Future. 2010]
ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN.
Carson J, Haddad D, Bressman M, Fong Y. Drugs Future. 2010; 35(3):183-195.
Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response. [Viruses. 2009]
Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response.
Shah AC, Parker JN, Shimamura M, Cassady KA. Viruses. 2009 Dec; 1(3):510-22. Epub 2009 Oct 22.
Oncolytic viruses: do they have a role in anti-cancer therapy? [Clin Med Oncol. 2008]
Oncolytic viruses: do they have a role in anti-cancer therapy?
Prestwich RJ, Errington F, Harrington KJ, Pandha HS, Selby P, Melcher A. Clin Med Oncol. 2008; 2:83-96. Epub 2008 Feb 9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null...
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.
Gene Ther. 2000 May ;7(10):859-66.

PubMed
Significant other responses are associated with fatigue and functional status am...
Significant other responses are associated with fatigue and functional status among patients with chronic fatigue syndrome.
Psychosom Med. 2000 May-Jun ;62(3):444-50.

PubMed
Endoscopic approach for the resection of forehead masses.
Endoscopic approach for the resection of forehead masses.
Plast Reconstr Surg. 2000 Jun ;105(7):2459-63.

PubMed
Intermediate filaments: molecular architecture, assembly, dynamics and polymorph...
Intermediate filaments: molecular architecture, assembly, dynamics and polymorphism.
Q Rev Biophys. 1999 May ;32(2):99-187.

PubMed
[Transcutaneous nervous stimulation in the treatment of hemicrania and other for...
[Transcutaneous nervous stimulation in the treatment of hemicrania and other forms of headache].
Minerva Med. 1976 Jun 23 ;67(31):2023-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma.

Source

Abstract

Comment in

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 60 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information